
PANCAID Consortium Selects biomodal’s duet 6-Base Mosaic Technology to Advance Early Pancreatic Cancer Detection
PANCAID Consortium Selects biomodal’s duet 6-base mosaic Technology to Support Early Detection of Pancreatic Cancer biomodal, an omics-based life sciences technology and analytics company, has announced that PANCAID (PANcreatic CAncer…














